FdaApplication

NDA 206406

Back to search

Identifiers

Properties

PropertyValue
applicant_nameVELOXIS PHARMACEUTICALS INC
application_typeNDA
approval_date2015-07-10

Products (3)

ProductActive ingredientStrengthDosage form
ENVARSUS XRTACROLIMUSEQ 0.75MG BASETABLET, EXTENDED RELEASE;ORAL
ENVARSUS XRTACROLIMUSEQ 1MG BASETABLET, EXTENDED RELEASE;ORAL
ENVARSUS XRTACROLIMUSEQ 4MG BASETABLET, EXTENDED RELEASE;ORAL

3 products